The RadExIORSBoost is Twinning project to Skyrocket Scientific Excellence Towards Individual Radiosensitivity Prediction by Raising the Bar in Knowledge Transfer, Networking, and Technological Innovation in Radiobiology, HORIZON-WIDERA 2023-ACCESS 02-01-Twinning Bottom-Up Grant No. 101158832.
The RadExIORSBoost project is tailored to improve access to scientific excellence, increase research management capabilities, and brain circulation across European Research Academy (ERA). RadExIORSBoost aims to investigate individual radiosensitivity of prostate cancer patients under radiation treatment, to design a high-quality clinical study, and to develop institutional Scientific Strategy on radiobiology. We hope our investigations will move one step closer towards understanding the molecular basis of adverse effects of radiation treatment.
#RadExIORSBoost: Advancing #radiobiology research to predict individual #radiosensitivity & personalize #cancer treatment. #prostatecancer #radiotherapy #transcriptome #biomarkers
Company Details
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Radexiorsboost Questions
Radexiorsboost's LinkedIn profile is https://www.linkedin.com/company/radexiorsboost
Radexiorsboost's industry is
Research Services
Radexiorsboost's top competitors are
Health Safety Environment Management,
Suisselle,
C4ir Srbija,
Neokliniken,
Carolina Baracho · Interiores,
Division Of Cancer Sciences,
Sociedad Argentina De Terapia Radiante Oncologica,
Niba Labs,
Imperial Prostate,
Elta 90 Medical Science.
Radexiorsboost's categories are Research Services
